Affiliation:
1. Department of Immunology and Transfusion Medicine Oslo University Hospital Oslo Norway
2. Institute of Clinical Medicine University of Oslo Oslo Norway
Abstract
AbstractBackgroundRefractory patients need to be provided with HLA‐matched platelets (PLTs), which require time‐consuming cross‐matching. Treatment of PLTs with citric acid leads to denaturation of the HLA Class I complexes without significant damage to the PLTs. HLA Class I depleted PLTs could alternatively be used to HLA‐matched PLTs for transfusion. These PLTs have verified normal function up to 4–6 h after acid treatment.Materials and MethodsBuffy coat (BC) PLT concentrates were depleted of HLA Class I complexes by incubation in citric acid. The days after acid‐treatment, surface expression of HLA Class I complexes, CD62P and CD63 were determined by flow cytometry, in addition to viability and mitochondrial membrane potential (MMP). Thromboelastography (TEG) tested PLT functionality.ResultsExpression of HLA Class I complexes was reduced by 70%–75% in acid‐treated PLTs compared to untreated PLTs from day 1 through day 7. Controls and acid‐treated PLTs showed insignificant loss of MMP stored for 4 days. Analysis of the residual PLT activation and viability showed no significant differences for 4 days of storage. However, the residual PLT activation potential and viability were significantly decreased in acid‐treated PLTs and control PLTs after 7 days of storage. Acid treatment caused a significant decrease in the TEG variable, reaction time (R time), for acid‐treated PLTs as compared to control PLTs from days 1 through day 3.ConclusionOur data suggest that extended storage of acid‐treated PLTs is possible and will improve flexibility when planning for transfusion of patients with alloimmune PLT refractoriness caused by anti‐HLA‐antibodies.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献